Article
Navigating the commercialization of cell and gene therapies
This article was originally published on European Pharmaceutical Review (EPR) on May 19, 2025
Kevin Chinn, VP and Head of Cell and Gene Service Line at Cencora, talks about the hurdles to making cell and gene therapy a commercial success – and how to leap over them.
Read the article to explore the potential and major obstacles impacting cell and gene therapies in the pharmaceutical industry.
Pardot Form
Connect with our cell and gene experts
Our tailored solutions address the unique challenges of advanced therapies, from early discovery through to patient delivery, ensuring that innovative treatments reach those who need them most. Connect with our expert team today to learn how Cencora can support your product’s journey.
